FIELD: medicine.
SUBSTANCE: A/17/quail/Hong Kong/97/84(H9N2) strain is prepared by genetic reassortation by crossing of apatogenic avian virus A/quail/Hong Kong/6/97(H9N2) and the cold-adapted thermally sensitive A/Leningrad/134/17/57(H2N2) strain - an attenuation donor. The prepared strain is deposited in the Collection of Viruses of Ivanovsky Research Institution of Virology of the Russian Academy of Medical Sciences, No. 2631.
EFFECT: applicability of the strain for producing the live intranasal vaccine or the inactivated influenza vaccine.
3 tbl
Authors
Dates
2012-10-20—Published
2011-05-24—Filed